Font Size:
a
A
A
Keyword [SGLT-2]
Result: 1 - 20 | Page: 1 of 2
1.
Studies On The Chemical Constituents And Bioactivities Of Gordonia Chrysandra And Gordonia Kwangsiensis
2.
Sglt - 2 Diabetes Drug Design And Synthesis Of Inhibitors
3.
Sglt - 2 Inhibitor Ertugliflozin Synthesis
4.
Effects Of SGLT-2 Inhibitors On Macrovascular Risk Factors In Type 2 Diabetes:a Systematic Review
5.
Research And Development Of Synthetic Process Of SGLT-2 Inhibitor
6.
Empagliflozin And Other Antidiabetic Agents For Type 2 Diabetes: A Systematic Review
7.
The Study Of The Synthesis Of The Drugs Against Type ? Diabetes—Ipragliflozin And The Key Intermediate Of Tofogliflozin
8.
The Interventional Study Of Empagliflozin,a SGLT-2 Inhibitor,on Ventricular Remodeling And Mitochondrial Function In Type 2 Diabetic Rats
9.
Effects Of SGLT-2 Inhibitors Combined With Insulin In Diabetes On Risk Factors Of Cardiovascular Disease: A Meta-analysis Of Randomized Controlled Trials
10.
Efficacy And Safety Of Triple Therapy With Sodium Glucose Co-transporter 2(SGLT-2)Inhibitor Add-on To Dipeptidyl Peptidase-4(DPP-4)Inhibitor Plus Metformin For Type 2 Diabetes:A Systematic Review
11.
Systematic Evaluation And Meta-analysis Of SGLT-2 Inhibitors Combined With Insulin In The Treatment Of Type 1 Diabetes
12.
Effects Of Sodium Glucose Cotransporter-2 Inhibitors On Lipids In Patients With Type 2 Diabetes:a Systematic Review
13.
The Effects Of Novelantidiabetic Drugs On Albuminuria In Type 2 Diabetes Mellitus
14.
Short-term Clinical Efficacy And Safety Of Dapagliflozin In The Treatment Of Type 2 Diabetes
15.
Effects Of Sodium Glucose Cotransporter-2 Inhibitors On Body Weight And Blood Pressure In Patients Of Type 2 Diabetes
16.
A Systematic Review And Meta-anaylsis On The Effects Of SGLT-2 Inhibitors On Insulin Resistance In Overweight And Obese Type 2diabetic Patients
17.
Meta Analysis Of The Effect Of SGLT2 Inhibitor On Oxidative Stress In Overweight Or Obese Type 2 Diabetic Patients
18.
The Effects Of SGLT-2 Inhibitors On Kidney Function In Patients With Type 2 Diabetes:A Meta-analysis
19.
Meta-analysis Of Efficacy And Safety Of SGLT-2 Inhibitors In The Treatment Of Patients With Type 2 Diabetes With Chronic Kidney Disease
20.
Synthesis And Pharmacodynamics Study Of A Dual SGLT-1/SGLT-2 Inhibitor
<<First
<Prev
Next>
Last>>
Jump to